USFDA issues 4 observations to Indoco Remedies’ Sterile facility at Goa

05 Jun 2023 Evaluate

The United States Food and Drug Administration (USFDA) has issued 4 observations in Form 483 to Indoco Remedies’ Sterile facility (Plant II) located at Goa. USFDA had inspected the said facility from February 20, 2023 to February 28, 2023. USFDA has determined the inspection classification of this facility as OAI (Official Action Indicated). The company is committed towards working with USFDA for remediation of the concerns on highest priority.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

210.20 -4.75 (-2.21%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×